Healthcare - Press Releases

VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces that U.S. FDA has completed its review of the PMA Module 2 submission and provided its feedback, in which the company sees no barrier for responding.

SHANGHAI and HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced that XPOVIO (selinexor) in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM) who have received at least two prior therapies, has been approved for reimbursement in Taiwan. Starting from March 1, 2025, XPOVIO will be officially included in the NHI drug reimbursement scheme.

Southern Star sets itself apart in the CRO market through a unique combination of trust, operational advantages, deep industry expertise, and a strong commitment to local resources.

SEOUL, South Korea, Feb. 12, 2025 /PRNewswire/ -- LG Chem is entering the global market with eco-friendly raw materials derived from vegetable oils. The company announced that it will commence the production of bio-acrylic acid in the second quarter of this year. Production capacity shall ramp up to 100 metric tons (MT) of prototype annually.

HO CHI MINH CITY, Vietnam, Feb. 13, 2025 /PRNewswire/ -- XDENT LAB, one of the leading providers in the field of Removable Denture manufacturing in Vietnam, has officially announced the expansion of its production facility, making it the largest in the country. This strategic move not only marks a significant leap for XDENT LAB in the dental industry but also reinforces its pioneering position in Lab-to-Lab services, targeting the U.S. market.

MAILAND, 13. Februar 2025 /PRNewswire/ -- Newronika, ein weltweit fhrendes Unternehmen im Bereich der fortgeschrittenen Tiefenhirnstimulation, freut sich, den erfolgreichen Abschluss seiner Finanzierungsrunde der Serie B in Hhe von 13,6 Mio. EUR bekannt zu geben. Die Finanzierung wurde von einem neuen Investor, der Fondazione ENEA Tech e Biomedical, gefhrt, mit zustzlicher Beteiligung der bestehenden Investoren Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital und F3F.

MILAN, Feb. 13, 2025 /PRNewswire/ -- Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its EUR13.6 million Series B funding round. The financing was led by a new investor, Fondazione ENEA Tech e Biomedical, with additional participation from existing investors Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital, and F3F.

MILAN, 13 fvrier 2025 /PRNewswire/ -- Newronika, leader mondial de la stimulation crbrale profonde avance, a le plaisir d'annoncer la clture russie de son tour de financement de srie B de 13,6millions d'euros. Le financement a t men par un nouvel investisseur, la Fondazione ENEA Tech e Biomedical, avec une participation supplmentaire des investisseurs existants Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital et F3F.

Global Financial Market Review (GFM) is a dedicated online news aggregation portal specializing in financial market news and industry updates. It combines original editorials with curated content from global news providers, reaching over 14 million readers annually. With a focus on reliability and depth, GFM has positioned itself as a trusted source in the financial sector, boasting a strong social media presence with over 180,000 Twitter followers.

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The fundus camera market and it is set to grow by USD 174.65 thousand from 2025 to 2029. However, the growth momentum will progressing at a CAGR of over 6.2% during the forecast period, according to Technavio. The fundus camera market is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market.Allm Inc., Canon Inc., Carl Zeiss AG, Chongqing Bio Newvision Medical Equipment Ltd., CSO ITALIA, Epipole Ltd., Essilor Instruments USA, Forus Health Pvt. Ltd., Haag Streit AG, Hongdee Ophthalmic Equipment, INTUVISION LABS, Kody Medical Electronics Pvt. Ltd., Kowa Co. Ltd., Marco, Mediworks, New Vision, NIDEK Co. Ltd., Optitech Eye Care, Optomed Oyj, PHELCOM, Remidio Innovative Solutions Pvt. Ltd., Revenio Group Oyj, Topcon Corp., VISIONIX USA INC., Volk Optical, and Zimed Healthcare Inc. Are some of the major market participants -.To know about the vendor offerings - Request a sample report

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global health and wellness food marketsize is estimated to grow by USD 627.6 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 9.8% during the forecast period. Increasing adoption of healthy eating habits is driving market growth, with a trend towards adoption ofprebiotic and probiotic food. However, high cost of health and wellness food poses a challenge. Key market players include Amys Kitchen Inc., Archer Daniels Midland Co., Bobs Red Mill Natural Foods Inc., Chobani Global Holdings LLC, Clif Bar and Co., Dairy Farmers of America Inc., Danone SA, Dr. Schar, Fifty50 Foods, General Mills Inc., Glanbia plc, GSK Plc, Kellogg Co., London Foods Ltd., Mars Inc., Mondelez International Inc., Nestle SA, PepsiCo Inc., United Natural Foods Inc., and Yakult Honsha Co. Ltd..

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The globalpharmaceuticals wholesale and distribution market size is estimated to grow by USD 896.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 9.45% during the forecast period. Growing global pharmaceutical salesis driving market growth,with a trend towardsemergence of drones in pharmaceuticals wholesale and distribution. However,increased complexities due to time-bound deliveries and customization of supply chain poses a challenge.Key market players include A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., MEDIPAL HOLDINGS CORP., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN CO. LTD., and The Cigna Group.

NOVATO, Calif., Feb. 11, 2025 /PRNewswire/ -- The sleek, modern quartz countertops that have become a staple of American homes are hiding a deadly secret. Hundreds of workers responsible for cutting and fabricating these fashionable artificial stone countertops are falling ill with acceleration silicosis, a fatal and incurable lung disease caused by inhaling toxic, nano-sized particles of silica dust and other toxins.

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global health and wellness marketsize is estimated to grow by USD 2.06 trillion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 7.1% during the forecast period. Increasing emphasis on promotion of health and wellness activities and programs is driving market growth, with a trend towards growing influence of thermal and mineral springs and spas. However, frequent product recalls poses a challenge. Key market players include Adidas AG,Amway Corp., Bayer AG, Beiersdorf AG, Core Health and Fitness LLC, Danone SA, David Lloyd Leisure Ltd., General Mills Inc., Glooko Inc., Herbalife International of America Inc., Johnson Health Tech Co. Ltd., LOreal SA, Nestle SA, Novo Nordisk AS, Ogilvie and Co., PepsiCo Inc., RSG Group GmbH, Shiseido Co. Ltd., The Procter and Gamble Co., Unilever PLC, and Vitabiotics Ltd..

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The globalmedical tourism market size is estimated to grow by USD 85.9 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.11% during the forecast period. Availability of low-cost treatment optionsis driving market growth,with a trend towardsgrowing focus on technological advancements. However,lack of advanced infrastructure in developing nations poses a challenge. Key market players include Anadolu Medical Center, Apollo International Ltd., Asian Heart Institute, Asian institute of medical sciences, Asklepios Kliniken GmbH and Co. KGaA, Athina Global Health, Bangkok Chain Hospital Public Co. Ltd, Bangkok Dusit Medical Services Public Co. Ltd., BNH Medical Centre Co. Ltd., Bumrungrad Hospital Public Co. Ltd, Clalit Research Institute, Clemenceau Medical Center, Dr. B. L. Kapur Memorial Hospital, Global Health Ltd., IHH Healthcare Berhad., Min Sheng General Hospital, Raffles Medical Group Ltd, Spire Healthcare Group Plc, The Cleveland Clinic Foundation, and The Johns Hopkins Health System Corp..

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The globalhome fitness equipment market size is estimated to grow by USD 4.44 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.38% during the forecast period. Increased demand for home fitness equipment is driving market growth, with a trend towards increasing smartphone penetration. However, rising popularity of other forms of workouts poses a challenge. Key market players includeANTA Sports Products Ltd., Core Health and Fitness LLC, Decathlon SA, Dyaco International Inc., HOIST Fitness Systems Inc., Icon Health and Fitness Inc., Impulse Qingdao Health Tech Co. Ltd., Johnson Health Tech Co. Ltd., Life Fitness, Nautilus Inc., Origin Fitness Ltd., Paradigm Health and Wellness Inc., Rama Enterprises, TECHNOGYM S.p.A, Torque Fitness, True Fitness Technology Inc., Tunturi New Fitness BV, Wattbike Ltd., WOODWAY Inc., and XMark Fitness.

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The globalwearable technology market size is estimated to grow by USD 99.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over17.3% during the forecast period. Popularity of wearable devices as a payment methodis driving market growth,with a trend towardsdevelopment of low-power electronics. However,rising penetration of counterfeit products poses a challenge. Key market players include Apple Inc., ASUSTeK Computer Inc., BAE Systems Plc, CINOPTICS, Citizen Watch Co. Ltd., Elbit Systems Ltd., Garmin Ltd., Google LLC, Huawei Technologies Co. Ltd., Kopin Corp., Lenovo Group Ltd., LG Corp., Magic Leap Inc., Misfit Inc., Polar Electro Oy, Samsung Electronics Co. Ltd., Sony Semiconductor Israel Ltd., Tex Ray Industrial Co. Ltd., Vuzix Corp., and Xiaomi Inc..

NEW YORK, Feb. 12, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The globalginseng market size is estimated to grow by USD 195.03 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.05% during the forecast period. Rising awareness of health benefits of ginsengis driving market growth,with a trend towardsincreased demand for organic ginseng products. However,high susceptibility of ginseng plants to pests and diseases poses a challenge. Key market players include AOS Products Pvt. Ltd., Auragin LLC, Bio Botanica Inc., Botalys SA, Herbal Creations, KAVYA PHARMA, Korea Ginseng Corp., MotherTree Nutra Pvt. Ltd., Natures Way Brands LLC, Nestle SA, Uniray Life Sciences, Velnex Medicare, Zoic Pharmaceuticals Pvt. Ltd., Bob Ginseng LLC, Canada Royal Enoch Phytomedicine Ltd., Ethical Naturals Inc., FREDERIC M, and G and G Century M Sdn Bhd.

OSLO, Norway, Feb. 12, 2025 /PRNewswire/ -- For the full year 2024,Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 531.3, which is 3.8 per cent up from 2023. Adjusted EBITDA amounted to NOK 46.6 million, compared to NOK 51.5 million last year. Gross margin ended at 39.3 per cent, up from 38.9 per cent in 2023.

RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ --Indivior PLC (Nasdaq/LSE: INDV)provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:

VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop for the treatment of acid reflux, a treatment field with 1 billion sufferers, is pleased to announce that the FDA has accepted Module 1 of the company's premarket approval (PMA) application, and that this module is now considered closed.

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.

Das Unternehmen gibt dieCE MDR-Zulassung fr sein neuartiges Neurodiagnose-Medizinprodukt Delphi-MD bekannt und bereitet sich damit auf die Vermarktung in der EU vor.

La socit annonce l'approbation CEMDR pour son nouveau dispositif mdical de neurodiagnostic Delphi-MD en vue de sa commercialisation dans l'UE, amliorant ainsi les rsultats cliniques et le bien-tre des patients tout en rduisant la charge financire des systmes de soins de sant et des payeurs.

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.